Curtas
| dc.Type | Article | pt_BR |
| dc.contributor.author | Instituto Nacional de Câncer José Alencar Gomes da Silva | |
| dc.contributor.author | Instituto Nacional de Câncer (Brasil) | |
| dc.contributor.author | INCA | |
| dc.date.accessioned | 2022-06-30T22:18:00Z | |
| dc.date.available | 2022-06-30T22:18:00Z | |
| dc.date.issued | 2016-05 | |
| dc.identifier.uri | http://sr-vmlxaph03:8080/jspui/handle/123456789/8372 | |
| dc.publisher | INCA | pt_BR |
| dc.subject | Vacinas contra Papillomavirus | pt_BR |
| dc.subject | Papillomavirus Vaccines | pt_BR |
| dc.subject | Vacunas contra Papillomavirus | pt_BR |
| dc.subject | Redução de Custos | pt_BR |
| dc.subject | Cost Savings | pt_BR |
| dc.subject | Ahorro de Costo | pt_BR |
| dc.subject | Neoplasias/prevenção & controle | pt_BR |
| dc.subject | Neoplasms/prevention & control | pt_BR |
| dc.subject | Neoplasias/prevención & control | pt_BR |
| dc.subject | Telemedicina | pt_BR |
| dc.subject | Telemedicine | pt_BR |
| dc.title | Curtas | pt_BR |
| dc.title.alternative | Informe INCA 347 | pt_BR |